Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2823 Lyon 1395 Bordeaux 1389 Marseille 1291 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris604 Novartis Pharmaceuticals68 Fondation Ophtalmologique Adolphe de Rothschild67 Institut National de la Santé Et de la Recherche Médicale, France64 AstraZeneca64
Site location
Paris2823 Lyon1395 Bordeaux1389 Marseille1291 Lille1281
All 809 locations
Target enrolment
to

Trials with a site in Paris

2823 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Neuroplasticity After Proprioceptive Rehabiliation
NCT05277519Stroke, Hemiparesis, Traumatic Brain Injury
Institut National de la Santé Et de la Recherche Médicale, France
Observational
56
Paris
2022-06-16
Recruiting
Priothera SAS
Phase 3
366
Angers, Lille, Lyon, Nancy, Nantes, Paris, Strasbourg, Toulouse
2022-06-16
Recruiting
Telios Pharma, Inc.
Phase 1/2
70
Angers, Marseille, Nice, Paris, Pierre-Bénite
2022-06-09
Active, closed
Sanofi
Phase 2
48
Bordeaux, Créteil, Paris, Toulouse
2022-06-09
Active, closed
Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX)
NCT05248477Newborn, Extreme Prematurity, Pretrm Infants
Assistance Publique - Hôpitaux de Paris
Not applicable
2,377
Paris
2022-06-01
Recruiting
Rituximab in Patients With ST-elevation Myocardial Infarction
NCT05211401ST Elevated Myocardial Infarction
Assistance Publique - Hôpitaux de Paris
Phase 2
372
Paris
2022-06-01
Active, closed
Centre Hospitalier Departemental Vendee
Not applicable
50
Créteil, La Roche-sur-Yon, Nantes, Paris
2022-05-31
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
189
Paris
2022-05-31
Active, closed
University Hospital, Angers
Observational
250
Angers, Corbeil-Essonnes, Créteil, Paris, Rennes
2022-05-30
Active, closed
Gilead Sciences
Phase 2
193
Boulogne-Billancourt, Brest, Caen, Clermont-Ferrand, Dijon, Le Mans, Paris, Pessac
2022-05-30
Recruiting
Bristol-Myers Squibb
Phase 2/3
120
Toulouse, Bron, Caen, Paris
2022-05-30
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Bordeaux, Créteil, Grenoble, La Roche-sur-Yon, Marseille, Montpellier, Paris, Saint-Priest-en-Jarez
2022-05-30
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
312
Bordeaux, Dijon, Marseille, Nantes, Paris, Poitiers, Saint-Herblain, Suresnes
2022-05-25
Recruiting
Deafness and Cognition in Middle-aged Adults
NCT05149742Mild Cognitive Impairment in Middle-aged Adults
Assistance Publique - Hôpitaux de Paris
Not applicable
180
Paris
2022-05-24
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Amiens, Angers, Bordeaux, Lille, Lyon, Marseille, Paris, Rennes
2022-05-23
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
750
Paris
2022-05-23
Recruiting
SELUTION4BTK Trial
NCT05055297Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
M.A. Med Alliance S.A.
Not applicable
376
Boulogne-Billancourt, Paris
2022-05-19
Recruiting
Institut Curie
Not applicable
2,050
Paris, Saint-Cloud
2022-05-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
175
Ivry-sur-Seine, Paris
2022-05-18
Recruiting
Molecular Diagnosis of Systemic Autoinflammatory Diseases
NCT05364294Inflammatory Disease, Genetic Disease, Somatic Mutation, Molecular Sequence Variation
Institut National de la Santé Et de la Recherche Médicale, France
Observational
300
Paris
2022-05-18
Active, closed
University Hospital, Bordeaux
Phase 1/2
80
Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris, Strasbourg
2022-05-17
Active, closed
AstraZeneca
Phase 3
644
Bordeaux, Dijon, Limoges, Lyon, Marseille, Montpellier, Paris, Rouen
2022-05-16
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
150
Paris
2022-05-16
Recruiting
Hoffmann-La Roche
Phase 2
40
Le Kremlin-Bicêtre, Paris, Toulouse
2022-05-12
Active, closed
Eli Lilly and Company
Phase 1
260
Lyon, Paris, Saint-Herblain, Strasbourg, Villejuif
2022-05-11
Recruiting
University Hospital, Brest
Not applicable
112
Brest, Angers, Grenoble, Lorient, Paris, Saint-Etienne
2022-05-11
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
20
Paris
2022-05-11
Recruiting
Innovacell GmbH
Phase 3
290
Paris, Rennes, Rouen
2022-05-11
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
100
Paris
2022-05-06
Recruiting
Incyte Corporation
Phase 2
98
Paris
2022-05-05
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
30
Besançon, Bordeaux, Lille, Limoges, Lyon, Montpellier, Nice, Paris
2022-05-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
50
Paris
2022-05-02
Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Esophageal Cancer, Radiotherapy, Side Effect, Proton Therapy
University of Aarhus
Phase 3
396
Lyon, Nice, Paris
2022-05-01
Recruiting
French Shoulder Instability Surgery Cohort Study
NCT07405827Shoulder Instability Subluxation Bilateral, Shoulder Instability
Chirurgie Du Sport
Observational
5,000
Paris
2022-05-01
Recruiting
Assessment in Patients With Essential Trigeminal Neuralgia of Nerve Involvement by MRI in DTI and Functional Connectivity in "Resting State"
NCT05051072Trigeminal Neuralgia, Microvascular Decompression Surgery, Diffusion Tensor Imaging
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
60
Paris
2022-04-27
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Rennes, Brest, Paris
2022-04-27
Active, closed
Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease
NCT05192616Angioplasty, Peripheral Arterial Disease, Iliac Artery Disease, Covered Stent
iVascular S.L.U.
Observational
241
Brest, Paris, Pessac, Villeneuve-d'Ascq
2022-04-27
Recruiting
EspeRare Foundation
Phase 2
20
Paris
2022-04-26
Recruiting
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
NCT05182164Soft Tissue Sarcoma Adult, Advanced Soft-tissue Sarcoma, Ewing Sarcoma, Osteosarcoma
DrugCabozantinib
Institut Bergonié
Phase 2
119
Bordeaux, Dijon, Lille, Lyon, Marseille, Paris, Saint-Herblain, Toulouse
2022-04-25
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
260
Paris
2022-04-22
Active, closed
European Myeloma Network B.V.
Phase 3
117
Nantes, Paris
2022-04-19
Active, closed
Sanofi
Phase 3
43
Paris
2022-04-18
Active, closed
Centre Hospitalier St Anne
Not applicable
12
Paris
2022-04-14
Active, closed
Verastem, Inc.
Phase 1/2
153
Lille, Paris, Suresnes
2022-04-12
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Angers, Paris, Poitiers, Amiens, Argenteuil, Béziers, Pierre-Bénite
2022-04-11
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
2,635
Paris
2022-04-08
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
130
Paris
2022-04-01
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
128
Paris
2022-04-01
Recruiting
Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children
NCT05237232Extra Corporeal Membrane Oxygenation, Decanulated Alive
Assistance Publique - Hôpitaux de Paris
Observational
30
Paris
2022-03-31
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 2/3
522
Créteil, Grenoble, Le Kremlin-Bicêtre, Limoges, Marseille, Paris, Pointe à Pitre, Saint-Ouen
2022-03-30
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Bordeaux, Lille, Paris
2022-03-29
Recruiting
The Patient Cohort of the National Center for Precision Medicine in Leukemia
NCT05326919Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome, Secondary Myelofibrosis in Myeloproliferative Disease
Assistance Publique - Hôpitaux de Paris
Observational
3,000
Bobigny, Paris
2022-03-28
Active, closed
Bayer
Phase 3
219
Bron, Strasbourg, Bordeaux, Montpellier, Toulouse, Paris
2022-03-28
Active, closed
AstraZeneca
Phase 3
760
Angers, Clichy, Créteil, Montpellier, Nantes, Nice, Paris, Strasbourg
2022-03-28
Active, closed
AstraZeneca
Phase 3
1,035
Bordeaux, Brest, Clermont-Ferrand, Créteil, Montpellier, Paris, Rouen, Saint-Herblain
2022-03-25
Active, closed
Pfizer
Phase 3
854
Toulouse, Paris, Villejuif, Poitiers, Lille, Pierre-Bénite, Tours
2022-03-25
Recruiting
AbbVie
Phase 3
768
Marseille, Lille, Montpellier, Pessac, Paris, Avignon, Bron, Lyon
2022-03-25
Active, closed
Novo Nordisk A/S
Phase 3
153
Chambéry, Le Kremlin-Bicêtre, Paris
2022-03-24
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
186
Paris
2022-03-23
Active, closed
Assistance Publique - Hôpitaux de Paris
Observational
69
Paris
2022-03-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
72
Paris
2022-03-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
40
Paris
2022-03-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Lyon, Strasbourg, Rennes, Chambray-lès-Tours, Besançon, Angers, Paris, Villejuif
2022-03-15
Recruiting
MRI Study of Subjects with ASD, Their Relatives and TD
NCT05470088Autism Spectrum Disorder
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,000
Gif-sur-Yvette, Paris
2022-03-13
Active, closed
BeOne Medicines
Phase 3
799
Antony, Le Mans, Montpellier, Nice, Paris, Strasbourg, VandoeuvrelesNancy
2022-03-10
Active, closed
Daiichi Sankyo
Phase 2
187
Créteil, Lyon, Marseille, Montpellier, Paris
2022-03-09
Recruiting
Janssen Research & Development, LLC
Phase 4
295
Nord, Paris
2022-03-09
Recruiting
ModernaTX, Inc.
Phase 1/2
56
Paris
2022-03-08
Active, closed
Centre Jean Perrin
Phase 1/2
66
Brest, Clermont-Ferrand, Grenoble, Lyon, Paris, Saint-Herblain, Strasbourg, Villejuif
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Avignon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2022-03-04
Recruiting
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
NCT05050864Pseudotumor Cerebri, Cerebrospinal Fluid, Transverse Sinuses
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
276
Paris
2022-03-02
Recruiting
Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors
NCT05799898Cancer, Immune Checkpoint Inhibitor, Cardiovascular Complication, Immune-related Adverse Event
Institut Mutualiste Montsouris
Observational
200
Paris
2022-03-01
Active, closed
Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma
NCT04874311Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma
DrugsBintrafusp alfa·Doxorubicin
Institut Bergonié
Phase 2
80
Bordeaux, Dijon, Lyon, Marseille, Paris, Poitiers
2022-03-01
Not yet open
Are Mast Cells Involved in Autoinflammatory Diseases
NCT05292768Autoinflammatory Disease, FMF, TRAPS, MKD
Assistance Publique - Hôpitaux de Paris
Observational
590
Paris
2022-03
Active, closed
Setrusumab vs Placebo for Osteogenesis Imperfecta
NCT05125809Osteogenesis Imperfecta
DrugSetrusumab
Ultragenyx Pharmaceutical Inc
Phase 2/3
183
Paris
2022-02-21
Recruiting
Genetic Susceptibility to Severe Infections
NCT06102070Infectious Disease
Institut National de la Santé Et de la Recherche Médicale, France
Observational
2,000
Paris
2022-02-18
Active, closed
Clinical Impact of the IBox As an Early Intervention TooL
NCT05112315Kidney Diseases, Kidney Disease, Chronic, Kidney Transplant Rejection, Kidney Transplant; Complications
Predict4Health
Not applicable
507
Paris, Toulouse
2022-02-18
Active, closed
AstraZeneca
Phase 3
791
Aix-en-Provence, Angers, Bobigny, Lille, Paris, Pau, Quimper, Saint-Grégoire
2022-02-18
Active, closed
Septodont
Observational
142
Levallois-Perret, Dijon, Muizon, Paris, Plérin, Saint-Amand-sur-Sèvre, Sézanne, Villiers-sur-Marne
2022-02-18
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
300
Paris
2022-02-17
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Nice, Dijon, Besançon, Brest, Toulouse, Lille, Paris, Saint-Herblain
2022-02-17
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 1/2
10
Paris, Pessac, Toulouse, Villejuif
2022-02-16
Active, closed
AstraZeneca
Phase 3
363
Aurillac, Bordeaux, Marseille, Paris, Strasbourg, Toulouse
2022-02-15
Active, closed
JCR Pharmaceuticals Co., Ltd.
Phase 3
86
Lyon, Montpellier, Paris
2022-02-14
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
180
Antony, Paris
2022-02-14
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2/3
286
Marseille, Bordeaux, Pointe à Pitre, Toulouse, Créteil, Paris
2022-02-11
Recruiting
Donepezil Versus Non-drug Treatment in Alzheimer's Disease.
NCT04661280Alzheimer Disease, Early Onset
DrugsAricept·Donepezil
Assistance Publique - Hôpitaux de Paris
Phase 3
240
Paris
2022-02-10
Active, closed
GE Healthcare
Phase 4
153
Dijon, La Tronche, Limoges, Lyon, Montpellier, Neuilly-sur-Seine, Nice, Paris
2022-02-08
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
1,200
Paris
2022-02-02
Active, closed
Amgen
Phase 1/2
329
Dijon, Lille, Paris, Villejuif
2022-02-01
Active, closed
Novartis Pharmaceuticals
Phase 2
41
Dijon, Montpellier, Paris
2022-01-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,400
Paris
2022-01-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
300
Brest, Lille, Montpellier, Paris, Strasbourg, Talence, Le Kremlin-Bicêtre
2022-01-20
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Bayonne, Besançon, Colombes, Nantes, Nice, Paris, Pierre-Bénite, Reims
2022-01-19
Recruiting
Respiratory Muscles and Work of Breathing in Children
NCT05051254Neuromuscular Diseases, Congenital Diaphragmatic Hernia, Lung Diseases, Cardiac Diseases
Assistance Publique - Hôpitaux de Paris
Not applicable
550
Paris
2022-01-19
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
152
Bordeaux, Lille, Lyon, Paris, Poitiers, Reims, Rennes, Saint-Mandé
2022-01-19
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
3,000
Paris
2022-01-19
By invitation
Institute of Cardiometabolism and Nutrition, France
Observational
20
Paris
2022-01-19
Active, closed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
NCT05002127Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
DrugsEvorpacept·Ramucirumab·Herceptin·Taxol
ALX Oncology Inc.
Phase 2/3
127
Besançon, Bordeaux, Brest, Lyon, Marseille, Paris, Toulouse
2022-01-15
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Pierre-Bénite, Paris
2022-01-14
Active, closed
Microvention-Terumo, Inc.
Observational
206
Brest, Limoges, Lyon, Marseille, Paris, Rouen
2022-01-14
Recruiting
The "Global Paradise System" Registry
NCT05027685Hypertension
ReCor Medical, Inc.
Observational
3,000
Grenoble, Bordeaux, Marseille, Paris, Pau
2022-01-13
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Nice, Lyon, Dijon, Toulouse, Paris, Nantes, Marseille, Créteil
2022-01-13
Recruiting
Fibromyalgia and Small Fiber Neuropathy
NCT06527183Chronic Pain Syndrome
Hospital Ambroise Paré Paris
Observational
150
Boulogne-Billancourt, Paris
2022-01-04
Active, closed
Centre Hospitalier Universitaire de Besancon
Phase 2
55
Besançon, Dijon, Levallois-Perret, Lyon, Montbéliard, Nice, Paris, Poitiers
2022-01-04
Recruiting
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)
NCT05009927Metastatic Gastrointestinal Stromal Tumor (GIST), C-KIT Mutation, Advanced Gastrointestinal Stromal Tumor (GIST)
DrugsGlivec·Imatinib
Centre Leon Berard
Phase 2
50
Besançon, Bordeaux, Limoges, Lyon, Marseille, Paris, Reims, Rennes
2022-01-03
Recruiting
Paris Translational Research Center for Organ Transplantation
Observational
600
Paris
2022-01-01
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
24
Paris
2021-12-31
Recruiting
Institut Curie
Not applicable
314
Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2021-12-28
Recruiting
Novartis Pharmaceuticals
Phase 1/2
34
Bordeaux, Lille, Paris, Poitiers
2021-12-27
Active, closed
Washington University School of Medicine
Phase 2/3
197
Toulouse, Lille, Paris, Bron, Rouen
2021-12-22
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 1/2
71
Paris
2021-12-22
Active, closed
Eli Lilly and Company
Phase 3
152
Lyon, Marseille, Rouen, Le Plessis-Robinson, Villejuif, Paris
2021-12-20
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Besançon, Clermont-Ferrand, La Roche-sur-Yon, Lyon, Marseille, Montpellier, Paris, Valenciennes
2021-12-17
Recruiting
Description of Lymphatic Damage in Encephalic Venous Thrombosis and Strictures in MRI a Reverse-recovery Sequence: a Pilot Study
NCT05041569Description of Local Modifications of Lymph Nodes or Bundles With the FABIR Sequence in MRI
Fondation Ophtalmologique Adolphe de Rothschild
Observational
100
Paris
2021-12-17
Recruiting
Queen Mary University of London
Phase 2
320
Paris
2021-12-16
Active, closed
Treat-to-target by Email During Urate-lowering Therapy in Gout
NCT04733079Gout, Inflammatory Rheumatism, Hyperuricemia, Posology Adjustment
Assistance Publique - Hôpitaux de Paris
Not applicable
204
Paris
2021-12-15
By invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
NCT05041309Solid and Hematological Malignancies, Autoimmune Diseases
DrugsKITE-197·SPRX002·KITE-753·Tecartus
Kite, A Gilead Company
Observational
1,500
Lille, Montpellier, Paris, Pessac, Pierre-Bénite, Rennes
2021-12-15
Active, closed
GlaxoSmithKline
Phase 2
360
Clichy, Lyon, Paris, Pessac, Rennes, Strasbourg
2021-12-14
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lyon, Marseille, Nice, Paris
2021-12-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Nice, Le Kremlin-Bicêtre, Nancy, Paris
2021-12-14
Recruiting
Institut Pasteur
Observational
90
Paris
2021-12-14
Active, closed
Alnylam Pharmaceuticals
Observational
207
Bordeaux, Lyon, Paris
2021-12-13
Active, closed
NTLA-2002 in Adults With Hereditary Angioedema (HAE)
NCT05120830Hereditary Angioedema
Intellia Therapeutics
Phase 1/2
37
Grenoble, Lille, Paris
2021-12-10
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
196
Paris
2021-12-09
Recruiting
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
NCT04150198Alzheimer Disease, Early Onset, Posterior Cortical Atrophy
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
45
Orsay, Paris
2021-12-08
Recruiting
Cochlear Implanted Listening Effort and Hearing Attention
NCT04733950Sensorineural Hearing Loss
Assistance Publique - Hôpitaux de Paris
Not applicable
170
Paris
2021-12-08
Recruiting
UCB Biopharma SRL
Phase 3
350
Bron, Dijon, Marseille, Paris, Rennes, Strasbourg
2021-12-07
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
325
Lyon, Paris, Toulouse
2021-12-06
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 2
222
Marseille, Paris, Pierre-Bénite, Rennes, Strasbourg, Toulouse, Villejuif
2021-12-01
Recruiting
Adult Tic Disorders Registry
NCT05090943Tic Disorders
Assistance Publique - Hôpitaux de Paris
Observational
450
Clermont-Ferrand, Limoges, Marseille, Paris, Poitiers, Saint-Herblain, Strasbourg
2021-12-01
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Amiens, Caen, Grenoble, Limoges, Nantes, Paris, Poitiers, Toulouse
2021-11-30
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
258
Créteil, Lyon, Marseille, Paris
2021-11-30
Active, closed
Womed
Not applicable
160
Le Kremlin-Bicêtre, Lille, Marseille, Paris, Rennes
2021-11-29
Recruiting
Direct Transcranial Electrical Stimulation in Tobacco Addiction (tDCS)
NCT04209153Adults (Male and Female Subjects) With Tobacco Dependence
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2021-11-29
Recruiting
Pfizer
Phase 3
245
Paris
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Avignon, Bron, La Tronche, Le Mans, Lille, Marseille, Montpellier, Paris
2021-11-17
Active, closed
Hoffmann-La Roche
Phase 3
41
Montpellier, Paris
2021-11-17
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 3
70
Marseille, Strasbourg, Bron, Lille, Le Kremlin-Bicêtre, Paris
2021-11-16
Recruiting
Central Hospital, Nancy, France
Not applicable
240
Nancy, Paris
2021-11-16
Active, closed
Centre Chirurgical Marie Lannelongue
Not applicable
200
Le Plessis-Robinson, Marseille, Paris
2021-11-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
240
Paris
2021-11-09
Recruiting
ModernaTX, Inc.
Phase 1/2
50
Marseille, Paris
2021-11-09
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
140
Paris, Poitiers, Toulouse
2021-11-09
Active, closed
Septodont
Observational
145
Colombes, Lyon, Nantes, Paris, Reims, Toulouse
2021-11-08
Recruiting
Fondation Hôpital Saint-Joseph
Observational
300
Paris
2021-11-05
Active, closed
Amgen
Phase 3
303
Créteil, Dijon, Le Chesnay, Lille, Marseille, Nantes, Nice, Paris
2021-11-02
Recruiting
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
NCT04942080Myeloproliferative Neoplasm, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage, Primary Myelofibrosis, Fibrotic Stage
University Hospital, Angers
Not applicable
260
Angers, Bordeaux, Brest, Cholet, Le Mans, Morlaix, Paris, Poitiers
2021-10-28
Recruiting
Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema
NCT04763577Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
University Hospital, Grenoble
Observational
243
Grenoble, Lille, Paris, Rouen
2021-10-27
Recruiting
Centre Hospitalier St Anne
Not applicable
240
Paris
2021-10-26
Active, closed
Hoffmann-La Roche
Phase 3
303
Paris
2021-10-26
Recruiting
argenx
Phase 2/3
12
Marseille, Paris
2021-10-26
Recruiting
Bayer
Phase 1/2
430
Lyon, Bordeaux, Nantes, Saint-Herblain, Marseille, Paris, Villejuif
2021-10-25
Active, closed
Hoffmann-La Roche
Phase 3
83
Montpellier, Paris
2021-10-22
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
168
Angers, Issy-les-Moulineaux, Nantes, Nîmes, Paris, Sèvres, Villejuif
2021-10-20
Active, closed
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
NCT05198674Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
1,899
Bordeaux, Paris
2021-10-20
Active, closed
A Long-term Extension Study of Ustekinumab in Pediatric Participants
NCT05092269Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic
DrugUstekinumab
Janssen Research & Development, LLC
Phase 3
159
Paris
2021-10-18
Recruiting
Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock
NCT04184635Acute Myocardial Infarction, Cardiogenic Shock
Assistance Publique - Hôpitaux de Paris
Not applicable
400
Paris
2021-10-14
Active, closed
AbbVie
Phase 1
520
Bordeaux, Saint-Herblain, Nice, Lyon, Villejuif, Dijon, Paris
2021-10-13
Recruiting
Centre Hospitalier Universitaire de Nīmes
Phase 3
180
Bordeaux, Le Kremlin-Bicêtre, Lyon, Nantes, Nîmes, Paris, Poitiers, Toulouse
2021-10-10
Active, closed
Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry
NCT04907240Peripheral Artery Disease, Popliteal Aneurysm, Hemodialysis Access, Visceral Artery Aneurysms
W.L.Gore & Associates
Observational
614
Angers, Brest, Lyon, Paris, Strasbourg
2021-10-09
Active, closed
Hoffmann-La Roche
Phase 2
176
Besançon, Caen, Lyon, Paris, Rennes, Saint-Herblain, Toulouse, Villejuif
2021-10-07
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Observational
70
Besançon, La Tronche, Nantes, Paris, Poitiers, Toulouse, Tours
2021-10-07
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 2
690
Lyon, Montpellier, Nantes, Nîmes, Paris, Pierre-Bénite
2021-10-07
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Bordeaux, Lyon, Nantes, Paris
2021-10-06
Recruiting
Pfizer
Phase 3
893
Limoges, Lille, Nantes, Paris, Pierre-Bénite, Poitiers, Toulouse
2021-10-04
Active, closed
Eli Lilly and Company
Phase 3
874
Strasbourg, La Chaussée-Saint-Victor, Besançon, Saint-Cloud, Montpellier, Le Mans, Bayonne, Paris
2021-10-04
Recruiting
Environment and Lung Cancer
NCT05119244Cannabis Use
Centre Chirurgical Marie Lannelongue
Not applicable
150
Le Plessis-Robinson, Paris, Villejuif
2021-10-01
Active, closed
University Paul Sabatier of Toulouse
Not applicable
1,025
Lyon, Marseille, Paris, Toulouse
2021-10-01
By invitation
European Society for Blood and Marrow Transplantation
Observational
197
Paris
2021-10
Active, closed
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
NCT04951856STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI
DrugsRepatha·Evolocumab
Assistance Publique - Hôpitaux de Paris
Phase 4
2,166
Paris
2021-09-29
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
180
Paris
2021-09-29
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
66
Paris
2021-09-24
Active, closed
Study of INBRX-109 in Conventional Chondrosarcoma
NCT04950075Conventional Chondrosarcoma
DrugINBRX-109
Inhibrx Biosciences, Inc
Phase 2
206
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Rennes
2021-09-23
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Grenoble, Lille, Nice, Paris, Strasbourg, Villejuif
2021-09-22
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
150
Paris
2021-09-22
Active, closed
Nantes University Hospital
Phase 2
45
Bordeaux, Nantes, Paris
2021-09-21
Recruiting
Nantes University Hospital
Observational
600
Nantes, Paris
2021-09-20
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Marseille, Montpellier, Paris
2021-09-20
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Le Mans, Montpellier, Morvan, Nantes, Paris, Pierre-Bénite, Politiers, Rennes
2021-09-20
Active, closed
Alligator Bioscience AB
Phase 1/2
94
Bordeaux, Lyon, Marseille, Paris, Vandœuvre-lès-Nancy
2021-09-17
Active, closed
Boston Scientific Corporation
Not applicable
155
Aix-en-Provence, Angers, Bordeaux, Grenoble, Lille, Lyon, Nice, Paris
2021-09-15
Recruiting
Cohort of Chronic Pain Patients
NCT04880096Chronic Pain
University Hospital, Clermont-Ferrand
Observational
5,000
Clermont-Ferrand, Boulogne-Billancourt, Paris, Amiens, Bayeux, Bordeaux, Bron, Grenoble
2021-09-14
Active, closed
Hoffmann-La Roche
Phase 1/2
42
Lyon, Marseille, Paris
2021-09-14
Active, closed
FH ORTHO
Observational
82
Brest, Garches, La Roche-sur-Yon, Paris
2021-09-14
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
DrugTacabrutideg
BeOne Medicines
Phase 1/2
689
Bordeaux, ClermontFerrand, Créteil, Lille, Lyon, Marseille, Montpellier, Paris
2021-09-13
Active, closed
Il-Yang Pharm. Co., Ltd.
Phase 2
43
Lille, Limoges, Lyon, Nantes, Paris, Poitiers, Rouen
2021-09-09
Recruiting
Amgen
Phase 3
60
Bron, Paris
2021-09-09
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
NCT05059444Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma, Non-small Cell Lung Cancer
Guardant Health, Inc.
Observational
2,285
Besançon, Levallois-Perret, Marseille, Neuilly, Paris
2021-09-07
Recruiting
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
NCT04934007Obsessive-Compulsive Disorder
Centre Hospitalier Henri Laborit
Not applicable
136
Paris, Poitiers
2021-09-06
Active, closed
Albireo, an Ipsen Company
Phase 3
62
Bron, Lille, Paris
2021-09-03
Active, closed
Nuvation Bio Inc.
Phase 2
217
Bron, La Tronche, Lyon 08, Marseille, Paris, Poitiers, Reims, Rennes
2021-09-01
Not yet open
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
NCT04702932Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia
Assistance Publique - Hôpitaux de Paris
Observational
30
Paris
2021-09-01
Recruiting
Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
NCT04925349Adrenoleukodystrophy, Adrenomyeloneuropathy, Metachromatic Leukodystrophy, Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
Assistance Publique - Hôpitaux de Paris
Observational
100
Le Kremlin-Bicêtre, Paris
2021-08-30
Recruiting
Biomarker Research in Inherited Movement Disorders
NCT05034172Inherited Movement Disorders, Spinocerebellar Ataxias, Hyperkinetic Disorders
Assistance Publique - Hôpitaux de Paris
Observational
4,000
Paris
2021-08-25
Active, closed
Sophia Genetics SAS
Observational
4,000
Bobigny, Bordeaux, Boulogne-Billancourt, Lyon, Nantes, Paris, Suresnes, Toulon
2021-08-21
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Lille, Nantes, Paris, Poitiers, Toulouse
2021-08-19
Recruiting
X-linked Moesin Associated Immunodeficiency
NCT06278337Immune Deficiency, Autoimmune Diseases, Infections, Diagnosis
Institut National de la Santé Et de la Recherche Médicale, France
Observational
16
Paris, Rennes, Saint-Etienne
2021-08-12
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Strasbourg, Lyon, Marseille, Le Kremlin-Bicêtre, Paris, Villejuif
2021-08-12
Active, closed
Pfizer
Phase 3
118
Bron, Paris
2021-08-12
Active, closed
HUYABIO International, LLC.
Phase 3
450
Besançon, Boulogne-Billancourt, Dijon, La Tronche, Lille, Marseille, Paris, Pierre-Bénite
2021-08-12
Active, closed
Tanabe Pharma America, Inc.
Phase 3
286
Bordeaux, Colombes, Nantes, Paris
2021-08-10
Active, closed
Biotronik AG
Observational
160
Narbonne, Paris
2021-08-10
Recruiting
University Medicine Greifswald
Observational
3,000
Paris
2021-08-06
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Bordeaux, Caen, Lille, Lyon, Marseille, Nantes, Nice, Paris
2021-08-04
Active, closed
Boston Scientific Corporation
Phase 4
544
Besançon, Nîmes, Paris
2021-08-02
Active, closed
Improvement of Live Babies Rates After ICSI, Using cpFT
NCT04954274Infertility, Oocyte, Pregnancy
Assistance Publique - Hôpitaux de Paris
Phase 3
366
Paris
2021-07-29
Recruiting
Novartis Pharmaceuticals
Phase 3
98
Lille, Marseille, Montpellier, Paris
2021-07-28
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Lille, Nantes, Nice, Paris, Toulouse
2021-07-27
Recruiting
Genentech, Inc.
Phase 1
186
Paris, Poitiers, Rennes
2021-07-26
Active, closed
University Hospital, Lille
Not applicable
320
Lille, Lyon, Nantes, Orléans, Paris, Poitiers, Vandœuvre-lès-Nancy
2021-07-23
By invitation
BioCryst Pharmaceuticals
Phase 3
139
Grenoble, Marseille, Paris
2021-07-23
Recruiting
Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
NCT04478409Familial Mediterranean Fever, MEFV Gene Mutation
Hospices Civils de Lyon
Observational
160
Bron, Le Chesnay, Lyon, Montpellier, Nîmes, Paris, Pierre-Bénite
2021-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
102
Nantes, Bordeaux, Bron, Marseille, Paris
2021-07-21
Active, closed
Boston Scientific Corporation
Not applicable
297
Grenoble, Lille, Nantes, Paris
2021-07-20
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Bron, Grenoble, Paris, Provence-Alpes-Côte d'Azur
2021-07-15
Active, closed
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
NCT04554914Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
DrugTabelecleucel
Pierre Fabre Medicament
Phase 2
190
Montpellier, Paris
2021-07-14
Active, closed
Hoffmann-La Roche
Phase 3
451
Bordeaux, Lyon, Marseille, Paris
2021-07-14
Active, closed
Bristol-Myers Squibb
Phase 3
670
Chambray-lès-Tours, Montpellier, Paris
2021-07-13
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Besançon, Lille, Paris
2021-07-13
Recruiting
Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform
NCT04927156Intracranial Aneurysm, Brain Arterial Disease, Acute Ischemic Stroke, Peripheral Vascular Diseases
Balt Extrusion
Observational
10,000
Angers, Bordeaux, La Tronche, Lille, Paris, Tours
2021-07-12
Active, closed
Bristol-Myers Squibb
Phase 2
74
Bordeaux, Créteil, Paris
2021-07-12
Recruiting
MED-EL Elektromedizinische Geräte GmbH
Not applicable
32
Paris
2021-07-10
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Clichy, Créteil, Lyon, Montpellier, Paris, Rennes, Strasbourg, Tours
2021-07-08
Recruiting
GYNOV
Not applicable
72
Paris
2021-07-07
Active, closed
Rennes University Hospital
Not applicable
239
Bobigny, Limoges, Lorient, Mulhouse, Orléans, Paris, Rennes, Saint-Brieuc
2021-07-02
Recruiting
Boehringer Ingelheim
Phase 1
554
Bron, Lyon, Marseille, Paris, Rennes, Villejuif
2021-07-02
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
1,500
Paris
2021-07-01
Recruiting
Hôpital NOVO
Phase 3
200
Auxerre, Corbeil-Essonnes, La Roche-sur-Yon, Paris, Poissy, Pontoise
2021-06-30
Active, closed
Neurocrine Biosciences
Phase 3
103
Angers, Bordeau, Le Kremlin-Bicêtre, Paris
2021-06-25
Active, closed
Hoffmann-La Roche
Phase 3
142
Créteil, Paris, Toulouse
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Marseille, Dijon, Toulouse, Lille, Poitiers, Paris
2021-06-25
Recruiting
Philips Clinical & Medical Affairs Global
Not applicable
594
Lyon, Montpellier, Paris
2021-06-23
Recruiting
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2
102
Bobigny, Nancy, Nantes, Nice, Paris, Pessac, Périgueux, Saint-Quentin
2021-06-18
Recruiting
French Parkinson's Disease Cohort - NS-PARK
NCT04888364Parkinson Disease
Institut National de la Santé Et de la Recherche Médicale, France
Observational
30,000
Paris
2021-06-16
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
103
Marseille, Nîmes, Montpellier, Clichy, Dijon, Paris, Rennes, Villejuif
2021-06-16
Active, closed
Novartis Pharmaceuticals
Phase 3
469
Angers, Bordeaux, Clermont-Ferrand, Lyon, Paris, Villejuif
2021-06-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
300
Paris
2021-06-15
Recruiting
Novartis Pharmaceuticals
Phase 4
130
Créteil, Paris
2021-06-10
Active, closed
Novartis Pharmaceuticals
Phase 3
1,140
Bordeaux, Clermont-Ferrand, Lyon, Montpellier, Nantes, Paris, Strasbourg, Vandœuvre-lès-Nancy
2021-06-09
Active, closed
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F
NCT04765345Retinal Degeneration, Retinitis Pigmentosa, Eye Diseases, Hereditary
Jaeb Center for Health Research
Observational
44
Paris
2021-06-08
Recruiting
ATF Implants
Observational
4,500
Bordeaux, Cornebarrieu, Échirolles, Guilherand-Granges, Marcq-en-Barœul, Nice, Paris, Poitiers
2021-06-07
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
NCT04165109Down Syndrome, Alzheimer Disease, Dementia
University of Southern California
Observational
550
Paris
2021-06-07
Recruiting
Sophysa
Observational
126
Marseille, Paris
2021-06-04
Recruiting
Prospective Study on the Consequences of Weight Loss After Bariatric Surgery on Obese Patients' Spine.
NCT04893954Low Back Pain in Obese Patients After Important Weight Loss
Assistance Publique - Hôpitaux de Paris
Not applicable
80
Paris
2021-06-03
Active, closed
Daiichi Sankyo
Phase 2
155
Dijon, Lille, Lyon, Paris, Pierre-Bénite, Toulouse
2021-06-03
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
200
Gentilly, Lille, Nice, Paris, Rouen
2021-06-02
Active, closed
Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes
NCT04583462Type 1 Diabetes, Peripheral Arterial Calcification
DrugMetformin
Assistance Publique - Hôpitaux de Paris
Phase 3
230
Paris
2021-06-02
Active, closed
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicable
617
Marseille, Paris, Villeurbanne
2021-06-01
Active, closed
Centre Jean Perrin
Not applicable
1,100
Clermont-Ferrand, Beaumont, Angers, Rennes, Saint-Herblain, Paris
2021-05-31
Active, closed
Nobel Biocare
Observational
1,000
Lyon, Montpellier, Paris
2021-05-26
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Lille, Nice, Paris
2021-05-24
Recruiting
Institut Curie
Not applicable
300
Boulogne-Billancourt, Paris, Saint-Cloud
2021-05-22
Active, closed
Daiichi Sankyo
Phase 3
490
Besançon, Brest, Lille, Lyon, Marseille, Montpellier, Paris, Saint-Priest-en-Jarez
2021-05-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
234
Paris
2021-05-20
Recruiting
GE Healthcare
Phase 1/2
54
Paris
2021-05-20
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Besançon, Marseille, Nantes, Paris, Pessac, Pierre-Bénite, Strasbourg, Toulouse
2021-05-19
Active, closed
CNS Pharmaceuticals, Inc.
Phase 2
252
Lyon, Marseille, Montpellier, Paris, Saint-Herblain, Toulouse, Villejuif
2021-05-18
Active, closed
Biogen
Phase 3
158
Paris
2021-05-17
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
La Rochelle, Massy, Nîmes, Paris, Pau, Rouen
2021-05-15
Active, closed
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
NCT04940325Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer, Unresectable Non-small Lung Cancer
DrugDato-DXd
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
100
Bordeaux, Brest, Caen, Créteil, Paris, Pierre-Bénite, Strasbourg, Villejuif
2021-05-12
Active, closed
Pfizer
Phase 3
599
Brest, Le Mans, Angers, Bayonne, Lille, Lyon, Paris, Pierre-Bénite
2021-05-12
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
139
Dijon, Limoges, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain
2021-05-11
Active, closed
Santen SAS
Not applicable
80
Brest, La Rochefoucauld, Lyon, Nantes, Paris, Le Kremlin-Bicêtre
2021-05-11
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
88
Paris
2021-05-10
Recruiting
Gustave Roussy Cancer Profiling
NCT04932525Solid Tumor, Unspecified, Adult
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
20,000
Villejuif, Le Plessis-Robinson, Paris, Suresnes
2021-05-10
By invitation
Cytokinetics
Phase 2/3
900
Marseille, Montpellier, Nantes, Paris, Pessac, Rennes, Toulouse
2021-05-06
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
40
Paris
2021-05-05
Active, closed
Murdoch Childrens Research Institute
Not applicable
906
Paris
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Angers, Avignon, Bordeaux, Clermont-Ferrand, Lyon, Nancy, Paris, Suresnes
2021-05-03
Recruiting
RECORDATI GROUP
Phase 2
12
Paris
2021-04-28
Recruiting
Alnylam Pharmaceuticals
Observational
150
Bordeaux, Paris, Toulouse
2021-04-26
Active, closed
AstraZeneca
Phase 3
1,157
Avignon, Besançon, Bordeaux, Caen, Le Mans, Montpellier, Nice, Paris
2021-04-26
Active, closed
Hoffmann-La Roche
Phase 3
557
Grenoble, Lille, Marseille, Montpellier, Nantes, Paris, Pessac, Rennes
2021-04-26
Active, closed
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
NCT04825743ST-elevation Myocardial Infarction (STEMI)
CeleCor Therapeutics
Phase 3
2,463
Aubervilliers, Boulogne-Billancourt, Créteil, Grenoble, Marseille, Montreuil, Paris, Rennes
2021-04-24
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
NCT04752722Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
DrugPhase 2
enGene, Inc.
Phase 1/2
350
Angers, Bordeaux, Lille, Lyon, Paris, Rouen
2021-04-22
Recruiting
Prediction of Post-stroke Motor Recovery
NCT04574037Stroke, Upper Limb Motor Deficit
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2021-04-21
Active, closed
Novartis Pharmaceuticals
Phase 2
236
Bordeaux, Dijon, Paris, Tours
2021-04-19
Active, closed
In Utero Fetoscopic Repair Program for Sacral Myelomeningoceles and Mye-LDM
NCT04770805Sacral Myelomeningocele, Neural Tube Defects, Spina Bifida
Assistance Publique - Hôpitaux de Paris
Not applicable
10
Paris
2021-04-16
Recruiting
ModernaTX, Inc.
Phase 1/2
77
Marseille, Paris
2021-04-15
Recruiting
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
NCT04580420Primary Hyperoxaluria Type 1, End Stage Renal Disease
DrugDcr-Phxc
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 2
28
Bron, Paris
2021-04-15
Active, closed
Incyte Corporation
Phase 3
654
Amiens, Angers, Bordeaux, Dijon, Le Chesnay, Nantes, Paris, Pontoise
2021-04-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
120
Bordeaux, Paris
2021-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Marseille, Besançon, Toulouse, Limoges, Beuvry, Angers, Pierre-Bénite, Paris
2021-04-14
Active, closed
Takeda
Phase 3
77
Paris, Saint-Priest-en-Jarez Cedex
2021-04-14
Active, closed
Eli Lilly and Company
Phase 3
101
Bron, Montpellier, Le Kremlin-Bicêtre, Poitiers, Paris
2021-04-13
Active, closed
Geron Corporation
Phase 3
327
Pierre-Bénite, Tours, Paris, Nantes, Nice, Le Mans, Brest
2021-04-12
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
140
Paris
2021-04-12
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Bordeaux, Paris, Lille, Vandœuvre-lès-Nancy, Politiers, Rouen, Nantes, Pessac
2021-04-08
Active, closed
Economic Evaluation of Prostatic Urethral Lift
NCT04726748Benign Prostatic Hyperplasia
University Hospital, Bordeaux
Observational
1,360
Lille, Montpellier, Paris, Pierre-Bénite, Talence, Tours
2021-04-08
Active, closed
Ipsen
Phase 1/2
727
Antibes, Lyon, Paris
2021-04-06
Recruiting
University Hospital, Bordeaux
Not applicable
1,800
Clermont-Ferrand, Massy, Paris, Pessac, Rennes, Saint-Etienne, Toulouse, Vandœuvre-lès-Nancy
2021-04-06
Recruiting
Remission Factors in Anorexia Nervosa
NCT04560517Anorexia Nervosa
Institut National de la Santé Et de la Recherche Médicale, France
Observational
275
Paris
2021-04-06
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Nice, Pierre-Bénite, Marseille, Le Chesnay, Paris
2021-04-05
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Angers, Clichy, Lille, Lyon, Nice, Paris, Pessac, Pierre-Bénite
2021-04-01
Active, closed
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT03915678Solid Tumor, Adult, Pancreatic Cancer, Virus-associated Tumors, Non Small Cell Lung Cancer
Institut Bergonié
Phase 2
247
Bordeaux, Brest, Caen, Dijon, Lille, Marseille, Paris, Poitiers
2021-03-31
Recruiting
Molecular Signature From Tumor to Lymph Nodes
NCT04677205Lung Cancer, Stage IIIA-cN2, Operated With Curative Intent, Primary Tumor Tissue Available
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Clamart, Marseille, Nice, Paris, Rennes, Strasbourg, Toulouse
2021-03-30
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
3,800
Grenoble, Bordeaux, Créteil, Paris
2021-03-30
Recruiting
Study of BEST1 Vitelliform Macular Dystrophy
NCT05809635Best Vitelliform Macular Dystrophy, Retinitis Pigmentosa
Columbia University
Observational
52
Paris
2021-03-30
Recruiting
Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder
NCT06027645Prematurity, Extreme Prematurity, Infant Development, Brain Damage
Marianne Barbu-Roth
Not applicable
50
Paris
2021-03-29
Recruiting
Boston Scientific Corporation
Observational
5,000
Le Plessis-Robinson, Paris
2021-03-29
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
27
Montpellier, Montreuil, Paris
2021-03-26
Recruiting
Guerbet
Phase 4
2,076
Paris, Strasbourg
2021-03-24
Recruiting
Bristol-Myers Squibb
Phase 3
153
Calais, Dijon, Nice, Paris
2021-03-23
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Brest, Marseille, Nice, Paris, Villejuif
2021-03-22
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
35
Paris
2021-03-20
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
La Roche-sur-Yon, Lille, Lyon, Nîmes, Paris, Pierre-Bénite, Rennes, Saint-Herblain
2021-03-18
Active, closed
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
NCT04591392Heart Septal Defect, Heart Septal Defects, Atrial, Heart Defects, Congenital, Cardiovascular Abnormalities
atHeart Medical
Not applicable
250
Bordeaux, Lille, Nantes, Paris, Toulouse
2021-03-12
Active, closed
University Hospital, Bordeaux
Not applicable
500
Bordeaux, Brest, Lille, Paris, Strasbourg
2021-03-10
Active, closed
Institut de Recherches Internationales Servier
Phase 1
28
Paris
2021-03-10
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
62
Bordeaux, Clermont-Ferrand, Créteil, Dijon, Lille, Montpellier, Nantes, Paris
2021-03-10
Active, closed
Centre Hospitalier Universitaire de Liege
Not applicable
80
Clamart, Paris
2021-03-09
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
96
Nîmes, Montpellier, Lyon, Nantes, Toulouse, Paris
2021-03-05
Recruiting
Syndax Pharmaceuticals
Phase 2
296
La Tronche, Strasbourg, Toulouse, Amiens, Lille, Nancy, Nantes, Paris
2021-03-04
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Paris
2021-03-02
Recruiting
Genethon
Phase 2/3
77
Bordeaux, Brest, Bron, Lille, Montpellier, Paris, Strasbourg
2021-03-01
Recruiting
Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients
NCT04653012Focal Epilepsy, Electrodes, Implanted, Cognitive Function, Neurophysiology
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
80
Paris
2021-02-28
Active, closed
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Phase 3
455
Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Paris
2021-02-25
Active, closed
AbbVie
Phase 1
81
Marseille, Bordeaux, Paris, Dijon, Toulouse
2021-02-23
Active, closed
Stichting European Myeloma Network
Phase 2
160
Bordeau, Dijon, Nantes, Paris, Strasbourg, Toulouse
2021-02-22
Recruiting
Biosense Webster, Inc.
Observational
8,000
Clermont-Ferrand, Lyon, Marseille, Paris, Rennes, Strasbourg, Talence
2021-02-22
Active, closed
Sellas Life Sciences Group
Phase 3
127
Amiens, Angers, Caen, Grenoble, Nantes, Paris, Pierre-Bénite, Poitiers
2021-02-08
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
100
Paris
2021-02-07
Active, closed
Hoffmann-La Roche
Phase 3
55
Paris
2021-02-04
Recruiting
A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT04901936Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Hemoglobinuria
DrugPegcetacoplan
Apellis Pharmaceuticals, Inc.
Phase 2
12
Paris
2021-02-04
Recruiting
Institut Cancerologie de l'Ouest
Phase 2
262
Angers, Bordeaux, Montpellier, Nice, Paris, Saint-Herblain, Toulouse
2021-02-03
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Toulouse, Nantes, Lyon, Brest, Grenoble, Paris, Rennes, Villejuif
2021-02-02
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
Créteil, Lyon, Montpellier, Mulhouse, Paris, Saint-Denis
2021-01-29
Recruiting
Health-Enhancing Adapted Physical Activity Program at "Mon Stade"
NCT04716322Exercise Therapy, Behavior and Behavior Mechanisms, Adherence, Patient, Lifestyle, Sedentary
Mon Stade Sports Medicine Centre
Not applicable
2,024
Paris
2021-01-28
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer
DrugsIrinotecan·Gemcitabine
Artios Pharma Ltd
Phase 1/2
542
Villejuif, Paris, Poitiers, Bordeau, Marseille
2021-01-27
Recruiting
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
NCT04248283Urinary Incontinence, Urinary Incontinence,Stress
Uromedica
Not applicable
167
Marseille, Nantes, Paris
2021-01-26
Recruiting
Sanofi
Phase 1/2
258
Lille, Nantes, Paris
2021-01-25
Active, closed
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2021-01-21
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
NCT04031677Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
250
Lyon, Montpellier, Paris, Strasbourg, Villejuif
2021-01-20
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
88
Paris
2021-01-13
Recruiting
University Hospital, Brest
Not applicable
140
Angers, Brest, Nantes, Paris, Ploemeur
2021-01-12
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
20
Paris
2021-01-12
Active, closed
Galderma R&D
Phase 3
500
Bordeaux, Brest, Nantes, Nice, Paris, Pierre-Bénite, Rouen, Saint-Etienne
2021-01-11
Active, closed
BioNTech SE
Phase 2/3
358
Bordeaux, Caen, Dijon, Marseille, Paris, Tours, Villejuif
2021-01-07
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
78
Amiens, Besançon, Clichy, Dijon, Lyon, Marseille, Paris, Pessac
2021-01-05
Recruiting
Safety Registry of a Fecal Microbiota Transplant Cohort
NCT06311006Clostridium Difficile Infections
Assistance Publique - Hôpitaux de Paris
Observational
305
Paris
2021-01-04
Recruiting
VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies
NCT04648124Vision Functional Brain Networks in Patients With Hereditary Retinal Dystrophies
Fondation Ophtalmologique Adolphe de Rothschild
Observational
200
Paris
2021-01-04
Active, closed
Amgen
Phase 1/2
181
Le Chesnay, Lille, Nice, Paris, Pierre-Bénite, Toulouse
2021-01-04
Active, closed
Verastem, Inc.
Phase 2
225
Besançon, Lyon, Montpellier, Paris
2020-12-21
Active, closed
Daiichi Sankyo
Phase 3
605
Besançon, Grenoble, Lyon, Marseille, Nantes, Paris, Poitiers, Rennes
2020-12-21
Active, closed
Novartis Pharmaceuticals
Phase 2
17
Paris
2020-12-18
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Grenoble, Lille, Paris, Pessac
2020-12-18
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
200
Paris
2020-12-17
Active, closed
Neurocrine Biosciences
Phase 3
182
Angers, Grenoble, Le Kremlin-Bicêtre, Nantes, Paris
2020-12-16
Recruiting
CHOUIHED Tahar
Not applicable
225
Châlons-en-Champagne, Eaubonne, Nancy, Paris, Sarreguemines, Strasbourg
2020-12-14
Recruiting
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
NCT04342546Breast Cancer, Capsular Contracture Associated With Breast Implant
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
250
Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain
2020-12-11
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Grenoble, Le Puy-en-Velay, Paris, Saint-Priest-en-Jarez, Valenciennes
2020-12-11
Active, closed
MeiraGTx Ocular UK Ltd
Phase 3
97
Paris
2020-12-04
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Observational
496
Dijon, Paris, Toulouse
2020-12-01
Active, closed
XVIVO Perfusion
Not applicable
230
Paris
2020-11-25
Active, closed
Eli Lilly and Company
Phase 3
312
Amiens, Bordeaux, Créteil, Lille, Marseille, Paris
2020-11-25
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Montpellier, Pessac, Vandœuvre-lès-Nancy, Paris, Nantes, Clermont-Ferrand
2020-11-25
Recruiting
Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
NCT04421846Status Epilepticus, Dysimmune Encephalopathy
Assistance Publique - Hôpitaux de Paris
Not applicable
400
Paris
2020-11-25
Active, closed
Science Corporation
Not applicable
38
Lyon, Bordeaux, Créteil, Marseille, Nantes, Paris
2020-11-24
Active, closed
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
NCT04603001Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPNs)
DrugsLY3410738·Azacitidine·Venetoclax
Eli Lilly and Company
Phase 1
260
Marseille, Paris, Pessac, Pierre-Bénite, Toulouse
2020-11-19
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
300
Angers, Caen, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2020-11-11
Active, closed
Prevail Therapeutics
Phase 1/2
35
Saint-Pierre, Lille, Paris
2020-11-09
Active, closed
Septodont
Not applicable
160
Paris, Rennes, Rouen, Saint-Grégoire
2020-11-06
Active, closed
Pfizer
Phase 3
114
Nantes, Paris
2020-11-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
70
Paris
2020-11-05
Active, closed
Genmab
Phase 1/2
543
Lille, Marseille, Paris, Pierre-Bénite
2020-11-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Caen, Créteil, Dijon, Lille, Limoges, Marseille, Paris, Pessac
2020-11-03
Recruiting
Effectiveness of Percutaneous Needle Aponeurotomy
NCT03797690Dupuytren Disease of Finger
Assistance Publique - Hôpitaux de Paris
Not applicable
120
Paris
2020-11-02
Active, closed
Novartis Pharmaceuticals
Phase 2
134
Lille, Marseille, Paris, Pierre-Bénite, Toulouse, Villejuif
2020-10-30
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
200
Paris
2020-10-30
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
80
Bobigny, Clermont-Ferrand, Paris, Toulouse
2020-10-28
Active, closed
Provention Bio, a Sanofi Company
Observational
188
Orléans, Bron, Dijon, Marseille, Nice, Paris, Pau
2020-10-26
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Chartres, Paris
2020-10-25
By invitation
Genetix Biotherapeutics Inc.
Observational
85
Paris
2020-10-21
Active, closed
Exelixis
Phase 3
575
Brest, Clermont-Ferrand, Dijon, Hyères, La Roche-sur-Yon, Nîmes, Paris, Quimper
2020-10-19
Active, closed
CHAMPION-AF Clinical Trial
NCT04394546Atrial Fibrillation, Stroke, Bleeding
DrugsNon-Vitamin K Anticoagulant·NOAC
Boston Scientific Corporation
Not applicable
3,000
Bron, Grenoble, Paris
2020-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bordeaux, Bron, Dijon, Le Mans, Lille, Nantes, Paris, Pessac
2020-10-13
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
506
Paris
2020-10-11
Recruiting
Bougie Sleeve Trial
NCT02937649Morbid Obesity
Assistance Publique - Hôpitaux de Paris
Not applicable
1,658
Boulogne-Billancourt, Caen, Clamart, Créteil, La Tronche, Limoges, Longjumeau, Paris
2020-10-08
Recruiting
QualiMed Innovative Medizinprodukte GmbH
Observational
198
Paris
2020-10-03
Active, closed
CARdiomyopathy in Type 2 DIAbetes Mellitus
NCT04303364Cardiomyopathy, Diabetic
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,256
Bron, Créteil, Grenoble, Marseille, Nantes, Paris
2020-10-02
Active, closed
University Hospital, Brest
Not applicable
70
Angers, Bordeaux, Grenoble, Lyon, Nantes, Paris, Rennes, Roscoff
2020-10-02
By invitation
The Medical Management in Patients Exposed to Weapons of Mass Destruction
NCT05026645Chemical Injury, Chemicals; Intoxication, Acute Respiratory Distress Syndrome, Distress Respiratory Syndrome
St. Justine's Hospital
Observational
1,000
Paris
2020-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bordeaux, Bron, La Tronche, Lille, Limoges, Marseille, Paris, Pessac
2020-09-30
Active, closed
Ipsen
Phase 3
161
Amiens, Créteil, Grenoble, Orléans, Paris, Pessac, Reims, Strasbourg
2020-09-24
Recruiting
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
NCT04558450Covid19, Arterial Stiffness, Endothelial Dysfunction, Diastolic Dysfunction
Assistance Publique - Hôpitaux de Paris
Not applicable
360
Nancy, Paris, Rouen
2020-09-21
Active, closed
argenx
Phase 2
229
Angers, Bordeaux, Clermont-Ferrand, Le Kremlin-Bicêtre, Limoges, Nantes, Nice, Paris
2020-09-18
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Brest, Bobigny, Dijon, Nantes, Paris, Pessac, Rouen
2020-09-16
Recruiting
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Phase 2
150
Paris
2020-09-15
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
700
Paris
2020-09-15
Active, closed
PREdiction of Chronic LUng Allograft Dysfunction
NCT03967340Lung Transplant Rejection
Nantes University Hospital
Observational
240
Bordeaux, Grenoble, Le Plessis-Robinson, Lyon, Marseille, Nantes, Paris, Strasbourg
2020-09-10
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2020-09-09
Active, closed
University Hospital, Brest
Not applicable
1,276
Morlaix, Agen, Angers, Brest, Clermont-Ferrand, Dijon, Limoges, Paris
2020-09-08
Recruiting
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
NCT04340986Cholangiocarcinoma, Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
1,250
Paris
2020-09-02
Active, closed
AbbVie
Phase 3
330
Nice, Nîmes, Pessac, Nantes, Pierre-Bénite, Chambéry, Angers, Paris
2020-08-31
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Caen, Créteil, Limoges, Marseille, Paris, Pessac, Pierre-Bénite, Poitiers
2020-08-25
Recruiting
Takeda
Phase 2
210
Angers, Épagny, Nantes, Nice, Paris, Pontoise, Talence
2020-08-19
Active, closed
Pfizer
Phase 3
77
Paris
2020-08-18
Active, closed
Hoffmann-La Roche
Phase 3
271
Créteil, Lille, Paris, Toulouse
2020-08-10
Active, closed
Incyte Corporation
Phase 2
112
Brest, Nice, Paris, Toulouse, Tours
2020-08-03
Recruiting
Centre Hospitalier St Anne
Not applicable
50
Paris
2020-07-27
Active, closed
Celgene
Phase 2
276
Lille, Montpellier, Paris, Pierre-Bénite, Rennes, Toulouse
2020-07-14
Active, closed
AstraZeneca
Phase 3
1,012
Besançon, Bordeaux, Marseille, Montpellier, Nice, Paris, Pierre-Bénite, Quimper
2020-07-13
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
160
Bron, Paris, Strasbourg
2020-07-13
Recruiting
Institut Curie
Not applicable
700
Paris
2020-07-08
Active, closed
Amplatzer Amulet LAAO vs. NOAC
NCT04226547Atrial Fibrillation, Stroke, Bleeding
DrugNOAC
Abbott Medical Devices
Not applicable
2,650
Clermont-Ferrand, Massy, Paris, Pessac
2020-07-07
Active, closed
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
NCT04258943Philadelphia Chromosome Positive CML, Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Chronic Phase Chronic Myelogenous Leukemia
DrugBosutinib
Children's Oncology Group
Phase 1/2
60
Lyon, Paris
2020-07-06
Recruiting
Biomarkers and Choroidal Neovascularization
NCT04439708Choroidal Neovascularization, Mineralocorticoid Excess
Institut National de la Santé Et de la Recherche Médicale, France
Observational
250
Paris, Suresnes
2020-07-06
Active, closed
Validation Study of WITHINGS BPM Core for the Detection of Atrial Fibrillation
NCT04464499Atrial Fibrillation, Arrhythmias, Cardiac, Cardiovascular Diseases
Withings
Observational
160
Bagnolet, Paris
2020-07-06
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
670
Paris
2020-07-02
Recruiting
Jules Bordet Institute
Not applicable
600
Lille, Marseille, Paris, Rouen, Strasbourg, Toulouse
2020-07-01
Recruiting
OCT-Angiography and Adaptive Optics in Patients With Memory Impairment
NCT04389437Amnesia, Alzheimer Disease, Lewy Body Disease, Parkinsons Disease With Dementia
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
450
Paris
2020-06-26
Active, closed
Sanofi
Phase 3
337
Ars-Laquenexy, Bayonne, Grenoble, La Roche-sur-Yon, Lille, Paris, Poitiers, Rennes
2020-06-16
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Lille, Lyon, Montpellier, Nantes, Paris, Poitiers, Toulouse
2020-06-12
Active, closed
Eli Lilly and Company
Phase 1
71
Lyon, Paris
2020-06-11
Recruiting
French National Cohort of People With Type 1 Diabetes
NCT04657783Diabetes Mellitus, Type 1, Cardiovascular Diseases, Hypoglycemia, Patient Participation
Fondation Francophone pour la Recherche sur le Diabete
Observational
15,000
Paris
2020-06-10
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
2,000
Paris
2020-06-05
Recruiting
University Hospital Heidelberg
Phase 1/2
91
Paris
2020-05-26
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Toulouse, Nice, Paris
2020-05-21
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
144
Nice, Paris
2020-05-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Avignon, Amiens, Paris
2020-05-19
Active, closed
AstraZeneca
Phase 2
240
Paris, Vandœuvre-lès-Nancy
2020-04-22
Recruiting
Impact of COVID19 Outbreak in Cardiac Acute Care
NCT04344912Acute Coronary Syndrome, Heart Failure, COVID
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2020-03-20
Recruiting
University of Oxford
Phase 3
70,000
Paris
2020-03-19
Recruiting
COVID-19 in PID Survey
NCT04459689Primary Immune Deficiency, COVID
Imagine Institute
Observational
200
Paris
2020-03-15
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
DrugRepotrectinib
Turning Point Therapeutics, Inc.
Phase 1/2
75
Lyon, Angers, Bordeaux, Marseille, Nantes, Paris, Villejuif
2020-03-12
Active, closed
First-in-Human Study of ICT01 in Patients With Advanced Cancer
NCT04243499Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company
Phase 1/2
293
Bordeaux, Lyon, Marseille, Nantes, Nice, Paris, Poitiers
2020-03-05
Recruiting
High Resolution Imaging for Analysis of MVNT
NCT04285125Benign Neuronal Desease
Fondation Ophtalmologique Adolphe de Rothschild
Observational
33
Bordeaux, Rennes, Rouen, Toulouse, Paris, Pierre-Bénite, Saint-Herblain
2020-03-05
Recruiting
Centre Leon Berard
Not applicable
168
Besançon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Paris, Poitiers
2020-03-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Dijon, Montpellier, Rennes, Nantes, Paris
2020-02-27
Recruiting
Pathogenic Study of Adult Immune Enteropathies
NCT04280510Celiac Disease, Autoimmune Enteropathy, Inflammatory Bowel Diseases
Institut National de la Santé Et de la Recherche Médicale, France
Observational
200
Créteil, Le Kremlin-Bicêtre, Paris
2020-02-27
Active, closed
University of Pittsburgh
Phase 3
173
Créteil, Paris
2020-02-26
Active, closed
Immunocore Ltd
Phase 1/2
410
Bordeaux, Villejuif, Lyon, Paris
2020-02-25
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Lyon, Lille, Montpellier, Toulouse, Marseille, Nice, Paris
2020-02-25
Active, closed
KANDO Research
Not applicable
302
Bordeaux, Toulouse, Avignon, Paris
2020-02-18
Active, closed
Eli Lilly and Company
Phase 3
261
Lyon, Marseille, Montpellier, La Tronche, Clermont-Ferrand, Paris
2020-02-17
Recruiting
APACHE Cohort (A Psoriatic Arthritis CoHort)
NCT03768271Cohort Study, Psoriatic Arthritis (PsA), Recent Peripheral Arthritis
Assistance Publique - Hôpitaux de Paris
Observational
425
Créteil, Montpellier, Paris
2020-02-12
Active, closed
Eli Lilly and Company
Phase 3
58
Bron, Le Kremlin-Bicêtre, Nîmes, Paris, Poitiers
2020-02-12
Active, closed
SparingVision
Not applicable
82
Paris
2020-02-12
Recruiting
Hospices Civils de Lyon
Phase 1/2
26
Pierre-Bénite, Bordeaux, Caen, Lille, Marseille, Nice, Paris, Rennes
2020-02-12
Active, closed
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
NCT04042025Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III, SMA
DrugsOnasemnogene Abeparvovec-xioi·Zolgensma
Novartis Gene Therapies
Phase 3
85
Paris
2020-02-10
Active, closed
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2
NCT04227535Rheumatoid Arthritis, Interstitial Lung Disease
Assistance Publique - Hôpitaux de Paris
Observational
509
Paris
2020-02-03
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Paris, Poitiers, Rennes
2020-01-29
Recruiting
Centre Leon Berard
Phase 2
455
Angers, Bordeaux, Caen, Lyon, Marseille, Nice, Paris, Rouen
2020-01-28
Recruiting
French Cardiology Society
Not applicable
140
Paris
2020-01-24
Recruiting
Eli Lilly and Company
Phase 2
105
Bordeaux, Lyon, Paris
2020-01-22
Active, closed
BeOne Medicines
Phase 3
955
Bordeaux, La Roche-sur-Yon, Le Mans, Paris, Tours
2020-01-16
Active, closed
Actelion
Phase 3
138
Lille, Marseille, Montpellier, Paris, Pessac, Toulouse
2020-01-16
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Phase 1/2
3
Paris
2020-01-10
Recruiting
University Hospital, Limoges
Phase 2
40
Bordeaux, Bron, Le Kremlin-Bicêtre, Limoges, Paris, Rennes, Rouen, Toulouse
2020-01-06
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Lille, Lyon, Marseille, Paris
2020-01-05
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Besançon, Bordeaux, Lille, Lyon, Montpellier, Nantes, Paris, Strasbourg
2020-01-01
Active, closed
Pfizer
Phase 3
1,068
Antony, Bayonne, Bordeaux, Brest, Limoges, Nancy, Paris, Strasbourg
2019-12-30
Active, closed
Withings
Observational
234
Paris, Saint-Denis
2019-12-20
Recruiting
Amgen
Phase 3
24
Bron, Paris
2019-12-20
Recruiting
Natural History of Duchenne Muscular Dystrophy
NCT03882827Duchenne Muscular Dystrophy
Genethon
Observational
220
Bordeaux, Brest, Bron, Lille, Marseille, Montpellier, Paris, Strasbourg
2019-12-19
Recruiting
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NCT03728049Aortic Valve Stenosis, Aortic Valve Insufficiency
University Hospital, Lille
Not applicable
944
Clermont-Ferrand, Lille, Montpellier, Nîmes, Paris, Pessac, Rennes, Strasbourg
2019-12-18
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Amiens, Angers, Lyon, Nice, Nîmes, Paris, Poitiers, Villejuif
2019-12-16
Active, closed
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
NCT04183166Squamous Cell Carcinoma of Head and Neck
Transgene
Phase 1/2
80
Bordeaux, Marseille, Paris, Toulouse, Villejuif
2019-12-12
Active, closed
C. R. Bard
Not applicable
477
Lille, Dijon, Paris, Pierre-Bénite, Reims, Strasbourg
2019-12-12
Active, closed
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
NCT04188548Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
DrugsImlunestrant·Alpelisib·Everolimus·Abemaciclib
Eli Lilly and Company
Phase 1
379
Paris, Strasbourg
2019-12-10
Recruiting
The University of Queensland
Not applicable
3,600
Paris
2019-12-10
Recruiting
LUMIERE on the FETUS
NCT04142606Pregnancy
Assistance Publique - Hôpitaux de Paris
Observational
1,500
Paris
2019-12-06
Recruiting
Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study
NCT04170634Metastases to Bone, Metastatic Breast Cancer, Metastatic NSCLC
Hospices Civils de Lyon
Observational
220
Angers, Annecy, Clermont-Ferrand, Contamine-sur-Arve, Lille, Lyon, Paris, Pierre-Bénite
2019-11-28
Active, closed
Effectiveness and Tolerability of Eqwilate in Real-life Conditions
NCT04106908VWD - Von Willebrand's Disease
Octapharma
Observational
38
Caen, Clamart, Paris, Rennes, Rouen, Saint-Denis, Saint-Etienne
2019-11-27
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847Movement Disorders, Parkinson Disease, Essential Tremor, Tremor
Abbott Medical Devices
Observational
1,000
Clermont-Ferrand, Saint-Etienne, Paris, Nice
2019-11-26
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Créteil, Marseille, Paris, Toulouse
2019-11-26
Active, closed
Gilead Sciences
Phase 2/3
72
Marseille, Paris
2019-11-21
Recruiting
Olgun Elicin
Not applicable
34
Paris
2019-11-20
Active, closed
Institut Curie
Observational
690
Paris, Vandœuvre-lès-Nancy
2019-11-15
Recruiting
Stryker Trauma and Extremities
Observational
417
Lyon, Paris, Saint-Herblain
2019-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Pessac, Caen, Pierre-Bénite, Lille, Nantes, Poitiers, Paris, Créteil
2019-11-13
Active, closed
AbbVie
Phase 1
85
Nice, Amiens, Paris, Toulouse
2019-11-08
Active, closed
Janssen Research & Development, LLC
Phase 2
208
Lille, Nantes, Paris
2019-11-07
Active, closed
AbbVie
Phase 1/2
218
Marseille, Toulouse, Paris, Nice, Pierre-Bénite, Le Chesnay
2019-11-06
Active, closed
Jules Bordet Institute
Phase 2
147
Dijon, Paris
2019-11-06
Active, closed
Ventricular Arrhythmia After Myocarditis in Sportsman
NCT03842592Myocarditis Acute, Ventricular Arrythmia
University Hospital, Angers
Not applicable
50
Angers, Brest, Paris, Rennes
2019-11-06
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
NCT04065399Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia
DrugsCobicistat·Revumenib
Syndax Pharmaceuticals
Phase 1/2
447
Paris, Pessac, Pierre-Bénite, Villejuif
2019-11-05
Active, closed
Bristol-Myers Squibb
Phase 3
461
Besançon, La Tronche, Montpellier, Paris, Rennes, Rouen
2019-11-05
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
163
Rennes, Brest, Marseille, Paris, Vandœuvre-lès-Nancy, Villejuif
2019-11-04
Recruiting
University Hospital, Strasbourg, France
Phase 2
40
Besançon, Nancy, Paris, Rennes, Strasbourg
2019-10-29
Active, closed
AstraZeneca
Phase 3
140
Dijon, Marseille, Montpellier, Nantes, Paris, Suresnes, Toulouse
2019-10-29
Active, closed
Bristol-Myers Squibb
Phase 3
790
Brest, Besançon, Bordeaux, Lille, Marseille, Nantes, Nice, Paris
2019-10-28
Recruiting
GlaxoSmithKline
Phase 1/2
184
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Toulouse
2019-10-25
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
32
Besançon, Créteil, Levallois-Perret, Lille, Lyon, Montpellier, Nantes, Paris
2019-10-23
Active, closed
Eli Lilly and Company
Phase 3
30
Le Kremlin-Bicêtre, Paris, Poitiers
2019-10-16
Recruiting
Cellectis S.A.
Phase 1/2
52
Nantes, Paris, Pierre-Bénite, Rennes
2019-10-14
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Besançon, Dijon, La Tronche, Lille, Lyon, Marseille, Nice, Paris
2019-10-08
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
857
Paris
2019-10-07
Recruiting
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
NCT03955445C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
225
Montpellier, Paris, Toulouse
2019-10-03
Recruiting
Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
NCT03881930Neuropathy, Ataxia, Proprioceptive Disorders, Balance; Distorted
Assistance Publique - Hôpitaux de Paris
Not applicable
40
Paris
2019-10-01
Active, closed
University of Zurich
Observational
540
Paris
2019-10-01
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
220
Issy-les-Moulineaux, Le Plessis-Robinson, Limoges, Marseille, Neuilly-sur-Seine, Paris
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Caen, Clichy, Lille, Montpellier, Nice, Paris, Pessac, Pierre-Bénite
2019-09-26
Active, closed
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study
NCT04038138Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Nice
Not applicable
100
Lille, Nice, Paris
2019-09-16
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
DrugsZiftomenib·Itraconazole·Midazolam
Kura Oncology, Inc.
Phase 1/2
263
Lille, Nantes, Paris, Pessac, Pierre-Bénite, Villejuif
2019-09-12
Active, closed
LITMUS Imaging Study
NCT05479721NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
University of Oxford
Observational
450
Angers, Paris
2019-09-04
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Bordeaux, Lyon, Marseille, Paris, Poitiers, Saint-Mandé, Villejuif
2019-09-04
Active, closed
Nyxoah S.A.
Not applicable
110
Angers, Créteil, Lille, Montpellier, Paris, Rennes, Toulouse
2019-09-01
Recruiting
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
NCT04832607AdV Infection, EBV Infection, CMV Infection, Stem Cell Transplant Complications
Tobias Feuchtinger
Phase 3
149
Lille, Lyon, Nancy, Paris
2019-08-27
Rows per page Showing 2001–2500 of 2823
Previous 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-france/city/paris?page=5

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,823 of those studies with a site in Paris.

How many clinical trials are recruiting in Paris?

1,625 of the 2,823 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 323 have not yet opened recruitment, 828 are active but closed to new participants, and 47 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.